Clinical Trial Update: A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating different oral formulations of NNC0487-0111 and how food affects its pharmacokinetics in adults who are overweight or obese.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED